152 related articles for article (PubMed ID: 7543624)
1. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis.
Lehto T; Honkanen E; Teppo AM; Meri S
Kidney Int; 1995 May; 47(5):1403-11. PubMed ID: 7543624
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis.
Honkanen E; Teppo AM; Meri S; Lehto T; Grönhagen-Riska C
Nephrol Dial Transplant; 1994; 9(11):1553-9. PubMed ID: 7870341
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
5. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.
Honkanen EO; Teppo AM; Grönhagen-Riska C
Kidney Int; 2000 Jun; 57(6):2343-9. PubMed ID: 10844604
[TBL] [Abstract][Full Text] [Related]
6. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
7. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.
Meri S; Lehto T; Sutton CW; Tyynelä J; Baumann M
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):923-35. PubMed ID: 8670172
[TBL] [Abstract][Full Text] [Related]
8. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy.
Schulze M; Donadio JV; Pruchno CJ; Baker PJ; Johnson RJ; Stahl RA; Watkins S; Martin DC; Wurzner R; Gotze O
Kidney Int; 1991 Sep; 40(3):533-8. PubMed ID: 1787650
[TBL] [Abstract][Full Text] [Related]
9. Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction.
Väkevä A; Lehto T; Takala A; Meri S
Scand J Immunol; 2000 Oct; 52(4):411-4. PubMed ID: 11013013
[TBL] [Abstract][Full Text] [Related]
10. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
Honkanen E; Teppo AM; Törnroth T; Groop PH; Grönhagen-Riska C
Nephrol Dial Transplant; 1997 Dec; 12(12):2562-8. PubMed ID: 9430852
[TBL] [Abstract][Full Text] [Related]
11. Adhesion molecules and urinary tumor necrosis factor-alpha in idiopathic membranous glomerulonephritis.
Honkanen E; von Willebrand E; Teppo AM; Törnroth T; Grönhagen-Riska C
Kidney Int; 1998 Apr; 53(4):909-17. PubMed ID: 9551397
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; Pisano L; D'Amico G
Am J Kidney Dis; 2001 Aug; 38(2):240-8. PubMed ID: 11479148
[TBL] [Abstract][Full Text] [Related]
13. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma.
Väkevä A; Jauhiainen M; Ehnholm C; Lehto T; Meri S
Immunology; 1994 May; 82(1):28-33. PubMed ID: 7519171
[TBL] [Abstract][Full Text] [Related]
15. Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules.
Hakulinen J; Meri S
Immunology; 1995 Jul; 85(3):495-501. PubMed ID: 7558140
[TBL] [Abstract][Full Text] [Related]
16. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy.
Endo M; Fuke Y; Tamano M; Hidaka M; Ohsawa I; Fujita T; Ohi H
Nephron Clin Pract; 2004; 97(4):c147-53. PubMed ID: 15331938
[TBL] [Abstract][Full Text] [Related]
17. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis.
Praga M; Paz Artal E; Hernández E; Segura J; Moreno MA; Morales JM; Rodicio JL
Nephrol Dial Transplant; 1997 Dec; 12(12):2576-9. PubMed ID: 9430854
[TBL] [Abstract][Full Text] [Related]
18. Renal C3 synthesis in idiopathic membranous nephropathy: correlation to urinary C5b-9 excretion.
Montinaro V; Lopez A; Monno R; Cappiello V; Manno C; Gesualdo L; Schena FP
Kidney Int; 2000 Jan; 57(1):137-46. PubMed ID: 10620195
[TBL] [Abstract][Full Text] [Related]
19. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.
Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF
Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
Hakulinen J; Meri S
Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
